DEA Places Brivaracetam Into Schedule V
The Drug Enforcement Administration placed brivaracetam into Schedule V of the Controlled Substances Act, in an interim final rule (here). Effective May 12, brivaracetam will be subject to new registration, labeling, recordkeeping, and import and export requirements. Comments on the listing are due June 13, it said.
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
(Federal Register 05/12/16)